Below are the most recent publications written about "Rotavirus Vaccines" by people in Profiles.
-
Omore R, Powell H, Sow SO, Jahangir Hossain M, Ogwel B, Doh S, Ochieng JB, Jones JCM, Zaman SMA, Awuor AO, Juma J, Kasumba IN, Roose A, Jamka LP, Nasrin D, Liu J, Keita AM, Traor? A, Onwuchekwa U, Badji H, Sarwar G, Antonio M, Sugerman CE, Mintz ED, Houpt ER, Verani JR, Widdowson MA, Tennant SM, Platts-Mills JA, Tate JE, Parashar UD, Kotloff KL. Norovirus Disease Among Children <5 Years in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018. Clin Infect Dis. 2023 04 19; 76(76 Suppl1):S114-S122.
-
Mijatovic-Rustempasic S, Immergluck LC, Parker TC, Laghaie E, Mohammed A, McFadden T, Parashar UD, Bowen MD, Cortese MM. Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix?. Hum Vaccin Immunother. 2017 04 03; 13(4):928-935.
-
Parker TC, Mohammed A, Leong T, Mays S, Jain S, Churchill V, Ali F, Immergluck LC. Rotavirus vaccination rate disparities seen among infants with acute gastroenteritis in Georgia. Ethn Health. 2017 12; 22(6):585-595.
-
Immergluck LC, Parker TC, Jain S, Laghaie E, Spandorfer P, Jerris RC, Bowen MD, Parashar UD, Cortese MM. Sustained Effectiveness of Monovalent and Pentavalent Rotavirus?Vaccines in Children. J Pediatr. 2016 05; 172:116-120.e1.
-
Mohammed A, Immergluck L, Parker TC, Jain S, Leong T, Anderson EJ, Jerris RC. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. Vaccine. 2015 Oct 13; 33(42):5670-5677.
-
Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, V?zquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul; 132(1):e25-33.
-
Garc?a-Puebla A, Garc?a-Fragoso L. Acute rotavirus gastroenteritis in children younger than 5 years of age after initiation of rotavirus immunization schedule. Bol Asoc Med P R. 2012 Jan-Mar; 104(1):4-7.
-
Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec; 128(6):e1474-81.
-
Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S76-84.
-
Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007 Dec; 26(12):1099-104.